Biosimilars: Launch Insights From the Field
How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.
How Digital Innovation Drives Improved Market Access Strategies
In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?
Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies
Download this new white paper from IHOC - Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies - to learn the key insights about the role HSSPs play in improving the patient experience and why patient and provider satisfaction are important data points for both payers and manufacturers to consider when deciding to include HSSPs in their networks.
The Economics Behind Patient Access
Executive Q&A: how pharmaceutical distributors are compensated and the value they deliver to the healthcare supply chain.
How to Navigate Cell and Gene Therapy Reimbursement: Part Two
An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.
How to Navigate Cell and Gene Therapy Reimbursement: Part One
An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.
What Do Payers Think About Digital Health Technologies
How are payers thinking about apps, wearables and other digital health technologies?
The Route to Market Access in Canada
Understanding the unique considerations for reimbursement in the Canadian pharmaceutical market.
Innovative Approaches to Improving Clinical Trial Success
Sam Herbert, President of World Courier, shares the factors that are driving trial sponsors to deploy innovative approaches to manage expenses and improve trial success.
The Future of Patient Assistance Programs in Canada
As global manufacturers of specialty pharmaceuticals look to enter the Canadian market, it is important to understand the Canadian healthcare landscape with the provision of patient support services being an important consideration.